- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00690664
Evaluation of Scalp and Hair Shaft With Biologic Markers in African American and Caucasian Hair
July 3, 2018 updated by: Wake Forest University
The purpose of this research study is to better understand African American hair and scalp, its biologic appearance and how this relates to African Americans' perceptions of their hair and scalp health.
Since most hair studies have looked at Caucasian hair and scalp, we will use a population of Caucasian subjects for comparison in evaluating various hair and scalp parameters.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
60
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
North Carolina
-
Winston-Salem, North Carolina, United States, 27157
- Wake Forest University Health Sciences Dermatology
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years to 60 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
Healthy female subjects between the ages of 21-60 will be enrolled in this study.
These subjects will be recruited from Wake Forest University Health Sciences Dermatology clinic and our Institutional Review Board (IRB) approved advertising.
Half of the participants will be African American and the other half will be Caucasian.
Description
Inclusion Criteria:
- Must be willing to sign informed consent
- Female from the ages of 21-60 years
- Must be willing to have a thorough scalp and hair shaft examination
- Must be willing to discuss hair care regimen currently and in the past
- Must have washed hair at least 48 hours prior to initial study visit
- Pregnant and nursing females will not be allowed in the study; a baseline pregnancy test will be done to exclude pregnancy on females of childbearing potential
- Must be >6 months (26 weeks) postpartum
- Must have sufficient contrast between scalp skin color and hair color
- Must have hair at least 2 inches long
- May have mild itching and mild scaling of the scalp
- Must be willing to have hair clipped and shaved to 1mm within an approximately 2.5cm test site
- Must be in good stable general health, with no current infections.
Exclusion Criteria:
- May not have sewn-in or glued hair pieces or extensions at the time of the study
- Must not cut hair during the study
- Must not have hair loss beyond what is considered normal in the opinion of the Investigator at the time of the study
- Must not color hair or have other salon-type procedures (relaxer, permanent, highlighting, etc.) performed within 2 weeks of the initial visit
- Must not have any other underlying scalp disorder that could interfere with the test procedures or findings
- Must not have lost ≥10% of body weight within the past 12 months
- Must not have been on a weight reduction program overseen by a physician or nutritionist within the past 12 months
- Has used hair growth products e.g. minoxidil in the past 18 months
- Has undergone a hair transplant or scalp reduction surgery
- Has participated in a hair growth study within the past 15 months
- Is currently participating in another clinical study at this or any other facility
- Is taking, for a chronic condition, any prescription or over the counter medication(s) that in the opinion of the Investigator are likely to affect the hair properties (e.g. immunosuppressive agents, corticosteroids; or chronic use of anti-inflammatory medication)
- Application of any over-the-counter or prescription drug to the scalp on a routine basis within the past 3 months including but not limited to retinoids (e.g. retinal, tretinoin, retinyl palmitate, retinyl acetate, retinyl propionate), topical corticosteroids, benzyl peroxide, or any topical hormone therapy (e.g. Eterna 27)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
B
Caucasian women
|
|
A
African American women
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Observe comparators of African American and Caucasian women's hair
Time Frame: 3 days
|
3 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Amy McMichael, MD, Wake Forest University Health Sciences
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 24, 2007
Primary Completion (Actual)
July 14, 2014
Study Completion (Actual)
July 14, 2014
Study Registration Dates
First Submitted
June 2, 2008
First Submitted That Met QC Criteria
June 2, 2008
First Posted (Estimate)
June 5, 2008
Study Record Updates
Last Update Posted (Actual)
July 6, 2018
Last Update Submitted That Met QC Criteria
July 3, 2018
Last Verified
July 1, 2018
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- IRB00002509
- 31716
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Scalp Health
-
Wake Forest UniversityCompleted
-
Hungkuang UniversityCompletedHair Condition | Hair Loss | Hair and Scalp Health | Sebum Production | Scalp HealthTaiwan
-
Hungkuang UniversitySchweitzer Biotech CompanyActive, not recruitingAlopecia | Hair Condition | Hair Loss | Hair Thinning | Sebum Production | Scalp Health | Hair HealthTaiwan
-
Bangladesh Medical UniversityNot yet recruiting
-
Seoul National University Bundang HospitalCompletedDandruff | Seborrhoeic Dermatitis of the ScalpSouth Korea
-
University Hospital, BrestRecruiting
-
Universitas AirlanggaKementerian Riset dan Teknologi / Badan Riset dan Inovasi Nasional, Indonesia and other collaboratorsCompleted
-
Tongji HospitalRecruitingSafety and Efficacy | Scalp Nerve BlockChina
-
Uppsala University HospitalCompletedQuestionnaire | Fetal Scalp SamplingSweden
-
Abramson Cancer Center at Penn MedicineRecruitingSkin Cancer Face | Skin Cancer ScalpUnited States